Protagonist Therapeutics
PTGX
#3892
Rank
NZ$4.37 B
Marketcap
$73.45
Share price
4.93%
Change (1 day)
107.89%
Change (1 year)

EPS for Protagonist Therapeutics (PTGX)

EPS in 2023 (TTM): -$4.39

According to Protagonist Therapeutics 's latest financial reports the company's current EPS (TTM) is -$4.74. In 2022 the company made an earnings per share (EPS) of -$4.60 an increase over its 2021 EPS that were of -$4.78.

EPS history for Protagonist Therapeutics from 2015 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.39-4.6%
2022-$4.60-3.7%
2021-$4.7835%
2020-$3.54-33.33%
2019-$5.3174.42%
2018-$3.04-20.74%
2017-$3.84-45.64%
2016-$7.0757.3%
2015-$4.49

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.86-18.66%๐Ÿ‡บ๐Ÿ‡ธ USA